Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
116.30
-0.20 (-0.17%)
Feb 26, 2026, 1:00 PM IDT

Novolog (Pharm-Up 1966) Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
5959257261,4091,5041,423
Market Cap Growth
-29.20%27.45%-48.50%-6.30%5.66%81.80%
Enterprise Value
5959046741,4701,4491,385
Last Close Price
1.171.761.322.522.652.68
PE Ratio
47.9923.39-29.6635.5335.52
Forward PE
-14.0214.0214.0214.0214.02
PS Ratio
0.300.460.440.931.201.25
PB Ratio
1.552.421.833.033.504.81
P/TBV Ratio
11.9517.4710.3713.199.0619.23
P/FCF Ratio
9.336.374.4316.0728.5143.30
P/OCF Ratio
7.685.843.6310.6218.0324.34
EV/Sales Ratio
0.300.450.410.981.151.22
EV/EBITDA Ratio
6.238.475.0114.4015.8117.29
EV/EBIT Ratio
21.2312.4312.5018.9020.8724.07
EV/FCF Ratio
9.326.234.1216.7727.4642.13
Debt / Equity Ratio
0.550.520.540.460.390.52
Debt / EBITDA Ratio
2.211.531.361.741.551.62
Debt / FCF Ratio
3.281.371.312.433.164.69
Net Debt / Equity Ratio
-0.03-0.13-0.040.09-0.17-0.07
Net Debt / EBITDA Ratio
-0.18-0.46-0.130.39-0.78-0.28
Net Debt / FCF Ratio
-0.20-0.34-0.110.46-1.36-0.67
Asset Turnover
0.630.690.630.640.560.52
Inventory Turnover
6.066.536.747.074.974.26
Quick Ratio
0.840.830.850.870.920.84
Current Ratio
0.960.960.960.981.030.99
Return on Equity (ROE)
3.29%10.54%-9.15%11.38%12.35%14.50%
Return on Assets (ROA)
0.55%1.56%1.29%2.06%1.94%1.66%
Return on Invested Capital (ROIC)
4.92%14.53%12.23%13.53%16.38%17.42%
Return on Capital Employed (ROCE)
4.90%12.60%8.90%11.40%11.60%12.70%
Earnings Yield
2.08%4.28%-5.79%3.37%2.81%2.81%
FCF Yield
10.72%15.69%22.57%6.22%3.51%2.31%
Dividend Yield
3.36%2.78%2.23%2.60%3.54%0.97%
Payout Ratio
161.26%101.17%-67.14%75.62%29.95%
Buyback Yield / Dilution
-0.02%0.04%0.94%-0.14%-9.08%-22.05%
Total Shareholder Return
3.30%2.82%3.18%2.46%-5.54%-21.09%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.